Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease

by Michael F. Egan, Yuki Mukai, Tiffini Voss, James Kost, Julie Stone, Christine Furtek, Erin Mahoney, Jeffrey L. Cummings, Pierre N. Tariot, Paul S. Aisen, Bruno Vellas, Christopher Lines, David Michelson
Published 2019-08-01

Perceptual category judgment deficits are related to prefrontal decision-making abnormalities in schizophrenia

by Thomas W Weickert, Thomas W Weickert, Thomas W Weickert, Alejandro eTerrazas, Alejandro eTerrazas, Llewellyn B. Bigelow, Jose A. Apud, Michael F. Egan, Daniel R Weinberger, Daniel R Weinberger
Published 2014-01-01

Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function.

by Lucas Kempf, Kristin K Nicodemus, Bhaskar Kolachana, Radhakrishna Vakkalanka, Beth A Verchinski, Michael F Egan, Richard E Straub, Venkata A Mattay, Joseph H Callicott, Daniel R Weinberger, Andreas Meyer-Lindenberg
Published 2008-11-01